Page last updated: 2024-10-29

amrinone and Cholera Infantum

amrinone has been researched along with Cholera Infantum in 2 studies

Amrinone: A positive inotropic cardiotonic (CARDIOTONIC AGENTS) with vasodilator properties, phosphodiesterase 3 inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.
amrinone : A 3,4'-bipyridine substituted at positions 5 and 6 by an amino group and a keto function respectively. A pyridine phosphodiesterase 3 inhibitor, it is a drug that may improve the prognosis in patients with congestive heart failure.

Research Excerpts

ExcerptRelevanceReference
"Clinical trials of intravenous amrinone were performed in 462 patients severely ill with congestive heart failure."5.05Clinical safety of intravenous amrinone--a review. ( Treadway, G, 1985)
" Adverse effects are minimal, with dosage limited predominantly by decreases in filling pressures."2.37Intravenous use of amrinone for the treatment of the failing heart. ( LeJemtel, T; Mancini, D; Sonnenblick, E, 1985)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mancini, D1
LeJemtel, T1
Sonnenblick, E1
Treadway, G1

Reviews

1 review available for amrinone and Cholera Infantum

ArticleYear
Intravenous use of amrinone for the treatment of the failing heart.
    The American journal of cardiology, 1985, Jul-22, Volume: 56, Issue:3

    Topics: Aminopyridines; Amrinone; Cardiac Complexes, Premature; Cardiac Output; Cardiotonic Agents; Drug Int

1985

Trials

1 trial available for amrinone and Cholera Infantum

ArticleYear
Clinical safety of intravenous amrinone--a review.
    The American journal of cardiology, 1985, Jul-22, Volume: 56, Issue:3

    Topics: Aminopyridines; Amrinone; Arrhythmias, Cardiac; Cardiotonic Agents; Clinical Trials as Topic; Drug I

1985